Karyopharm Therapeutics (KPTI) Capital Expenditures (QoQ) (2014 - 2022)
Karyopharm Therapeutics (KPTI) Capital Expenditures (QoQ) (2014 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Karyopharm Therapeutics | 56.72 Mn | 56.72 Mn | 32.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -61.84% |
| Dec 31, 2021 | 4,040.00% |
| Jun 30, 2020 | 60.00% |
| Mar 31, 2020 | -80.00% |
| Dec 31, 2019 | -53.27% |
| Mar 31, 2019 | -95.52% |
| Dec 31, 2018 | 122.61% |
| Sep 30, 2018 | 23.68% |
| Jun 30, 2018 | 3.93% |
| Mar 31, 2018 | 594.55% |
| Jun 30, 2016 | -84.62% |
| Mar 31, 2016 | -98.22% |
| Dec 31, 2015 | 241.47% |
| Sep 30, 2015 | -359.73% |
| Jun 30, 2015 | 234.83% |
| Mar 31, 2015 | 107.86% |
| Dec 31, 2014 | -208.37% |
| Sep 30, 2014 | 301.92% |
| Jun 30, 2014 | 316.00% |
| Mar 31, 2014 | 290.63% |